Literature DB >> 18774412

Abacavir and increased risk of myocardial infarction.

Frank A Post, Lucy J Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18774412     DOI： 10.1016/S0140-6736(08)61330-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.

Authors:  Andy I Choi; Eric Vittinghoff; Steven G Deeks; Cristin C Weekley; Yongmei Li; Michael G Shlipak
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

2.  No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.

Authors:  Heather J Ribaudo; Constance A Benson; Yu Zheng; Susan L Koletar; Ann C Collier; Judith J Lok; Marlene Smurzynski; Ronald J Bosch; Barbara Bastow; Jeffrey T Schouten
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

Review 3.  Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

Authors:  R Martin-Iguacel; J M Llibre; N Friis-Moller
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

Review 4.  Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.

Authors:  Chad J Achenbach; Kimberly K Scarsi; Robert L Murphy
Journal:  Adv Ther       Date:  2010-03-05       Impact factor: 3.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.